3-iodo-alpha-methyltyrosine has been researched along with thallium in 1 studies
| Studies (3-iodo-alpha-methyltyrosine) | Trials (3-iodo-alpha-methyltyrosine) | Recent Studies (post-2010) (3-iodo-alpha-methyltyrosine) | Studies (thallium) | Trials (thallium) | Recent Studies (post-2010) (thallium) |
|---|---|---|---|---|---|
| 83 | 9 | 1 | 4,958 | 159 | 531 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bénard, F; Hustinx, R; Romsa, J | 1 |
1 review(s) available for 3-iodo-alpha-methyltyrosine and thallium
| Article | Year |
|---|---|
Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
Topics: Brain; Brain Neoplasms; Choline; Fluorodeoxyglucose F18; Glioma; Methionine; Methyltyrosines; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |